Efficacy and Safety of Belimumab in Subjects With Primary Sjögren's Syndrome

NCT01160666 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Sjögren's Syndrome

Interventions

DRUG: Belimumab

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]